Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 71,138 | 83,336 | 84,069 | 81,803 | 73,463 |
| Cost of Goods | 49,648 | 50,754 | 48,557 | 47,368 | 45,117 |
| Gross Profit | 21,490 | 32,582 | 35,512 | 34,435 | 28,346 |
| Operating Expenses | 56,760 | 69,574 | 51,419 | 54,516 | 48,258 |
| Operating Income | -34,622 | -36,238 | -15,350 | -19,713 | -19,795 |
| Interest Expense | 17 | 16 | 28 | 17 | 14 |
| Other Income | 8,661 | 6,980 | 7,869 | -1,789 | 8,086 |
| Pre-tax Income | -25,978 | -29,274 | -7,509 | -21,519 | -11,723 |
| Income Tax | -704 | -5,624 | -683 | -2,263 | 176 |
| Net Income Continuous | -25,274 | -23,650 | -6,826 | -19,256 | -11,899 |
| Minority Interests | -448 | -232 | -218 | -299 | -369 |
| Net Income | $-24,826 | $-23,418 | $-6,608 | $-18,957 | $-11,530 |
| EPS Basic Total Ops | -0.80 | -0.77 | -0.21 | -0.62 | -0.37 |
| EPS Basic Continuous Ops | -0.82 | -0.76 | -0.22 | -0.63 | -0.39 |
| EPS Diluted Total Ops | -0.80 | -0.77 | -0.21 | -0.62 | -0.37 |
| EPS Diluted Continuous Ops | -0.82 | -0.76 | -0.22 | -0.63 | -0.39 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.11 | -0.16 | -0.25 | -0.30 |
| EBITDA(a) | $-29,512 | $-40,994 | $-483 | $-15,065 | $-15,534 |